

Minolexin® in complex therapy of papulo-pustular acne of moderate severity (results of own research)
https://doi.org/10.33667/2078-5631-2023-24-74-78
Abstract
The aim of the study. A retrospective analysis of the results of complex therapy of moderate papulo-pustular acne with minocycline 50 mg per day orally and 15 % azelaic acid gel topically under natural ultraviolet irradiation.
Materials and methods. In a retrospective study, data from outpatient charts and the results of studying the morpho-functional parameters of the facial skin of 61 people (31 acne patients and 30 healthy individuals) were analyzed. Patients received oral minocycline (Minolexin®) 50 mg per day for 6 weeks and topically 15 % azelaic acid gel 2 times a day for 12 weeks in the period from April to September.
Results and discussion. The therapy was effective: clinical cure occurred in 90.3 % (n = 28), clinical remission – in 9.7 % (n = 3) patients. Rapid regression of papulo-pustules was achieved through the use of minocycline, which had antibacterial and anti-inflammatory effects. After treatment, elevated values of sebumetry, skin relief, pore size, and pigmentation were normalized in the group of patients with acne, due to the action of a topical gel, as well as the absence of photosensitizing effect in minocycline. Systemic and local adverse events registered in outpatient records were of a temporary nature and did not require discontinuation of therapy.
About the Author
I. M. KhismatulinaRussian Federation
Khismatulina Irina M., PhD Med, associate professor at Dept of Dermatovenerology
Kazan
References
1. Federal clinical guidelines. Dermatovenerology, 2020. Acne Vulgaris (L70). Russian Society of Dermatovenerologists and Cosmetologists. (In Russian). https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020/files/КР%20Акне%202020.docx
2. Ju et al. Chinese Guidelines for the Management of Acne Vulgaris: 2019 Update. International Journal of Dermatology and Venereology. 2019. V. 2. No. 3. P. 129–138. DOI: 10.1097/JD9.0000000000000043.
3. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016. V. 74. No. 5. P. 945–973. DOI: 10.1016/j.jaad.2015.12.037.
4. Nast A., Dréno B., Bettoli V., Bukvic Mokos Z., et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. Journal of the European Academy of Dermatology and Venerology. 2016. V. 30. No. 8. P. 1261–1268. DOI: 10.1111/jdv.13776.
5. Instructions for the use of the medicinal product for medical use Minolexin®. Reg. No. LP-(000754)-(RG-RU) from 04.05.22 (In Russian)] https://www.vidal.ru/drugs/molecule-in/1199
6.
Review
For citations:
Khismatulina I.M. Minolexin® in complex therapy of papulo-pustular acne of moderate severity (results of own research). Medical alphabet. 2023;(24):74-78. (In Russ.) https://doi.org/10.33667/2078-5631-2023-24-74-78